Restoring Continence After Devastating Post‐Obstetric Fistula Repair Incontinence: A Pilot Study Comparing Cystoscopic vs Periurethral Bulkamid
Neurourology and Urodynamics · 10.08.2026
DOI: 10.1002/nau.70407 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurourology and Urodynamics, online erschienen am 10.08.2026. Verfasst von Aidan J Kennedy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Corewell Health William Beaumont University Hospital, Royal Oak, Michigan, USA. Die Arbeit nennt 15 Literaturangaben.
Themen: Inkontinenz
Abstract (Originalsprache)
Introduction
Post‐obstetric fistula repair incontinence (POFRI) refers to persistent urinary leakage after successful fistula closure. This study evaluated Bulkamid for POFRI using two techniques: cystoscopic‐guided injections versus periurethral injections without cystoscopy. Materials and Methods We performed a prospective study of women with POFRI and persistent stress urinary incontinence (SUI) treated with Bulkamid at the Freedom from Fistula unit in Tamatave, Madagascar. Cohort 1 underwent cystoscopic Bulkamid injection; Cohort 2 underwent periurethral Bulkamid injection without cystoscopy. The International Consultation on Incontinence Questionnaire‐Urinary Incontinence Short Form (ICIQ‐UI SF), Questionnaire for Urinary Incontinence Diagnosis (QUID), and pad weight testing were obtained at baseline, discharge, and 3 months postoperatively. The primary outcome, Patient Global Impression of Improvement (PGI‐I), was collected at discharge and 3‐month follow‐up.
Results
In January 2025, Cohort 1 ( n = 11) underwent cystoscopic injection, and in June 2025, Cohort 2 ( n = 17) underwent periurethral injection. The primary outcome was met by 8/11 (72.7%) patients in Cohort 1 at discharge and 2/5 (40%) at 3 months. In Cohort 2, 11/17 (64.7%) patients met the primary outcome at discharge and 6/10 (60%) at 3 months. Combined, 19/28 (67.9%) patients achieved “success” at discharge and 8/15 (53.3%) at 3 months. At 3 months, both cohorts demonstrated significant reductions in mean QUID ( p < 0.001) and ICIQ‐UI‐SF scores ( p = 0.011). Two patients developed recurrent vaginal fistulas, both successfully repaired.
Conclusions
Bulkamid provided promising short‐term outcomes for SUI in women with POFRI. Both cystoscopic and periurethral approaches were effective, the periurethral technique was simpler and avoided cystoscopy. Larger studies with longer follow‐up are needed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Corewell Health William Beaumont University Hospital, Royal Oak, Michigan, USA.
- Freedom from Fistula Clinic, Analankininina University Hospital Center, Tamatave, Madagascar.
ORCID-Profile: Aidan J Kennedy, Nikta Rezakahn Khajeh, Bernadette M M Zwaans
Zitieren
APA
Kennedy, A. J., Breen, M., Khajeh, N. R., Zwaans, B. M. M., Peters, K. M., & Sirls, L. T. (2026). Restoring Continence After Devastating Post‐Obstetric Fistula Repair Incontinence: A Pilot Study Comparing Cystoscopic vs Periurethral Bulkamid. Neurourology and Urodynamics. https://doi.org/10.1002/nau.70407
Vancouver
Kennedy AJ, Breen M, Khajeh NR, Zwaans BMM, Peters KM, Sirls LT. Restoring Continence After Devastating Post‐Obstetric Fistula Repair Incontinence: A Pilot Study Comparing Cystoscopic vs Periurethral Bulkamid. Neurourology and Urodynamics. 2026. doi:10.1002/nau.70407
BibTeX
@article{Kennedy2026,
author = {Kennedy, Aidan J and Breen, Michael and Khajeh, Nikta Rezakahn and Zwaans, Bernadette M M and Peters, Kenneth M and Sirls, Larry T},
title = {Restoring Continence After Devastating Post‐Obstetric Fistula Repair Incontinence: A Pilot Study Comparing Cystoscopic vs Periurethral Bulkamid},
journal = {Neurourology and Urodynamics},
year = {2026},
doi = {10.1002/nau.70407}
}
EUVIMED